TVRD
Tvardi Therapeutics
TVRD
TVRD
136 hedge funds and large institutions have $83.3M invested in Tvardi Therapeutics in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 37 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less capital invested
Capital invested by funds: $166M → $83.3M (-$83.1M)
55% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 47
Holders
136
Holding in Top 10
–
Calls
$327K
Puts
$37K
Top Buyers
| 1 | +$2.89M | |
| 2 | +$2.07M | |
| 3 | +$1.77M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$1.67M |
| 5 |
ClearBridge Investments
New York
|
+$1.45M |
Top Sellers
| 1 | -$11M | |
| 2 | -$6.05M | |
| 3 | -$3.59M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.78M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.54M |